Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HP INCHPQ · Entity 642 | Director · Interim CEO | February 03, 2026 | February 05, 2026 |
| KEYCORP /NEW/KEY · Entity 3220 | Director | July 01, 2021 | July 06, 2021 |
| MARSH & MCLENNAN COMPANIES, INC.MRSH · Entity 1501 | Director | August 15, 2026 | August 18, 2026 |
| TAKEDA PHARMACEUTICAL CO LTDTAK · Entity 2662 | Director | July 01, 2026 | July 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HP INC
Report date February 03, 2026 · Filed February 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 344,149 |
Reported balance
After 2026-02-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-02-03 · Grant · Acquired 344,149 · Balance 344,149 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock. F2: On 2/3/2026, the reporting person was granted 344,149 RSUs, all of which vest on 2/3/2027. Dividend equivalent units accrue with respect to these RSUs when and as dividends are paid on HP common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.
F2: On 2/3/2026, the reporting person was granted 344,149 RSUs, all of which vest on 2/3/2027. Dividend equivalent units accrue with respect to these RSUs when and as dividends are paid on HP common stock.
KEYCORP /NEW/
Report date July 01, 2021 · Filed July 06, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 19,587 |
Reported balance
After 2021-07-01 transaction · row 1
1 source rowRow 1 · 2021-07-01 · Exercise / conversion · Acquired 6,781 · Balance 19,587 F1: Each Deferred Share is the economic equivalent of one Common Share. |
| Deferred SharesSEC Table II · derivative / convertible security · Expires 2021-07-01 | Direct | 27,263 |
Reported balance
After 2021-07-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-07-01 · Exercise / conversion · Disposed 6,781 · Balance 27,263 F1: Each Deferred Share is the economic equivalent of one Common Share. F3: Includes approximately 288 dividend-equivalent deferred shares accrued under the Deferred Share Plan in June 2021. |
| Common SharesSEC Table I · non-derivative | IndirectBy Trust | 11,778 |
Reported balance
Holding disclosure · report date 2021-07-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 11,778 F2: These shares are held in a living trust. The reporting person is trustee of the trust. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Deferred Share is the economic equivalent of one Common Share.
F2: These shares are held in a living trust. The reporting person is trustee of the trust.
F3: Includes approximately 288 dividend-equivalent deferred shares accrued under the Deferred Share Plan in June 2021.
MARSH & MCLENNAN COMPANIES, INC.
Report date August 15, 2026 · Filed August 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,617 |
Reported balance
After 2026-08-15 transaction · row 1
1 source rowRow 1 · 2026-08-15 · Grant · Acquired 192 · Balance 1,617 F1: Acquired in connection with director fees pursuant to the Marsh & McLennan Companies Directors Stock Compensation Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Acquired in connection with director fees pursuant to the Marsh & McLennan Companies Directors Stock Compensation Plan.
TAKEDA PHARMACEUTICAL CO LTD
Report date July 01, 2026 · Filed July 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| American Depositary SharesSEC Table I · non-derivative | Direct | 4,595 |
Reported balance
After 2026-07-01 transaction · row 1
1 source rowRow 1 · 2026-07-01 · Grant · Acquired 3,800 · Balance 4,595 F1: Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on June 1, 2029. |
| Tax Obligation AwardSEC Table II · derivative / convertible security · Expires 2029-06-01 | Direct | 1,319 |
Reported balance
After 2026-07-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-01 · Grant · Acquired 1,319 · Balance 1,319 F2: Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on June 1, 2029.
F2: Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
HUMANA INC
Report date July 01, 2024 · Filed July 01, 2024
Section 16 reporting ended · disclosed 2024-07-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Humana CommonSEC Table I · non-derivative | Direct | 85,130 |
Reported balance
Holding disclosure · report date 2024-07-01 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 85,130 F8: Includes 21,786 restricted stock units granted on 2/21/24, representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. |
| Humana CommonSEC Table I · non-derivative | IndirectSee Footnote | 25,000 |
Reported balance
Holding disclosure · report date 2024-07-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 25,000 F9: Shares transferred to GRAT effective January 30, 2024 in which reporting person is sole trustee. |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $350.79 · Expires 2027-02-24 | Direct | 13,430 |
Reported balance
Holding disclosure · report date 2024-07-01 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 13,430 F1: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments. |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $376.61 · Expires 2028-02-22 | Direct | 30,425 |
Reported balance
Holding disclosure · report date 2024-07-01 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 30,425 F2: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments on 2/22/22, 2/22/23, & 2/22/24. |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $425.06 · Expires 2029-02-21 | Direct | 23,734 |
Reported balance
Holding disclosure · report date 2024-07-01 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 23,734 F3: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments on 2/21/23, 2/21/24, & 2/21/25. |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $510.24 · Expires 2030-02-24 | Direct | 26,484 |
Reported balance
Holding disclosure · report date 2024-07-01 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 26,484 F4: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,184 |
Reported balance
Holding disclosure · report date 2024-07-01 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 2,184 F5: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 4,573 |
Reported balance
Holding disclosure · report date 2024-07-01 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 4,573 F5: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. |
Filing footnotes · ownership attribution and instrument terms
F1: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments.
F2: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments on 2/22/22, 2/22/23, & 2/22/24.
F3: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments on 2/21/23, 2/21/24, & 2/21/25.
F4: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26.
F5: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
F6: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.
F7: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.
F8: Includes 21,786 restricted stock units granted on 2/21/24, representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.
F9: Shares transferred to GRAT effective January 30, 2024 in which reporting person is sole trustee.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 20, 2022 Filed Nov 7, 2022 18:56 UTC | HUMANA INC HUM · Entity 1429 | GiftHumana Common | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-021636 · form4.xml · nonDerivative · entry 12 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,602 F15 · shares: Shares represent a charitable gift/donation, effective September 20, 2022, in which no value was received in return. Read SEC document |
| September 20, 2022 Filed Nov 7, 2022 18:56 UTC | HUMANA INC HUM · Entity 1429 | GiftHumana Common | 2,981 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-021636 · form4.xml · nonDerivative · entry 11 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,602 F14 · shares: Shares transferred represent a gift to a Trust in the name of affiliate's daughter, effective September 20, 2022. Affiliate is not a Trustee and has no pecuniary interest or investment discretion. Read SEC document |
| September 20, 2022 Filed Nov 7, 2022 18:56 UTC | HUMANA INC HUM · Entity 1429 | GiftHumana Common | 2,981 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-021636 · form4.xml · nonDerivative · entry 10 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,583 F13 · shares: Shares transferred represent a gift to a Trust in the name of affiliate's son, effective September 20, 2022. Affiliate is not a Trustee and has no pecuniary interest or investment discretion. Read SEC document |
| April 19, 2022 Filed Apr 21, 2022 21:07 UTC | HP INC HPQ · Entity 642 | GrantCommon Stock | 5,687 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025200 · doc4.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,710 F1 · shares: On April 19, 2022, the reporting person was granted 5,687 restricted stock units, all of which vested on the grant date. Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 21:45 UTC | HP INC HPQ · Entity 642 | PurchaseCommon Stock | 6,810 | $36.67 | $249,722.70 |
DisclosureSEC source: 0001209191-22-022038 · doc4.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,023 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $36.25-$36.75, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:22 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 11,360 | $428.27 | $4,865,147.20 |
DisclosureSEC source: 0001062993-22-006113 · form4.xml · nonDerivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,649 F11 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Performance Stock Units on 2/25/22. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:22 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 29,754 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006113 · form4.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,009 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · shares: Performance Stock Units vested on 2/25/22, not required to be reported until vest. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 23:09 UTC | HUMANA INC HUM · Entity 1429 | GrantRestricted Stock Units · Derivative | 6,551 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-005412 · form4.xml · derivative · entry 9 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,551 Underlying: Humana Common · 6,551 shares Expires not disclosed F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F9 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. F9 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 23:09 UTC | HUMANA INC HUM · Entity 1429 | GrantOptions · Derivative | 23,734 | $0.00 Strike: $425.06 | $0.00 |
DisclosureSEC source: 0001062993-22-005412 · form4.xml · derivative · entry 6 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,734 Underlying: Humana Common · 23,734 shares Expires 2029-02-21 F5 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments. F5 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 15:55 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 2,464 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013077 · form4.xml · derivative · entry 13 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,929 Underlying: Humana Common · 2,464 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F9 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23. F9 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 15:55 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 2,673 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013077 · form4.xml · derivative · entry 12 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,673 Underlying: Humana Common · 2,673 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F8 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22. F8 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 15:55 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 3,045 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013077 · form4.xml · derivative · entry 11 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 3,045 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/25/2019, 33% of the award is vesting on 12/15/19, 12/15/20, and 12/15/21. F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/25/2019, 33% of the award is vesting on 12/15/19, 12/15/20, and 12/15/21. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 15:55 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 970 | $459.85 | $446,054.50 |
DisclosureSEC source: 0001062993-21-013077 · form4.xml · nonDerivative · entry 6 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,255 Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 15:55 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 2,464 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013077 · form4.xml · nonDerivative · entry 5 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,225 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 15:55 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 1,052 | $459.85 | $483,762.20 |
DisclosureSEC source: 0001062993-21-013077 · form4.xml · nonDerivative · entry 4 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,761 Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 15:55 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 2,673 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013077 · form4.xml · nonDerivative · entry 3 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,813 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 15:55 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 1,199 | $459.85 | $551,360.15 |
DisclosureSEC source: 0001062993-21-013077 · form4.xml · nonDerivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,140 Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 15:55 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 3,045 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013077 · form4.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,339 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 15:21 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionOptions · Derivative | 26,939 | $0.00 Strike: $307.97 | $0.00 |
DisclosureSEC source: 0001062993-21-010469 · form4.xml · derivative · entry 6 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,470 Underlying: Humana Common · 40,409 shares Expires 2026-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/25/2019, vesting in three annual increments. F2 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/25/2019, vesting in three annual increments. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 15:21 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionOptions · Derivative | 14,346 | $0.00 Strike: $268.47 | $0.00 |
DisclosureSEC source: 0001062993-21-010469 · form4.xml · derivative · entry 5 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 372 Underlying: Humana Common · 14,718 shares Expires 2025-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/19/2018, vesting in three annual increments. F1 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/19/2018, vesting in three annual increments. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 15:21 UTC | HUMANA INC HUM · Entity 1429 | SaleHumana Common | 8,721 | $457.40 | $3,989,013.31 |
DisclosureSEC source: 0001062993-21-010469 · form4.xml · nonDerivative · entry 4 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,294 F10 · price: Reported price is weighted average sales price. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 15:21 UTC | HUMANA INC HUM · Entity 1429 | SaleHumana Common | 41,285 | $454.13 | $18,748,752.92 |
DisclosureSEC source: 0001062993-21-010469 · form4.xml · nonDerivative · entry 3 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,015 F10 · price: Reported price is weighted average sales price. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 15:21 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 26,939 | $307.97 | $8,296,269.14 |
DisclosureSEC source: 0001062993-21-010469 · form4.xml · nonDerivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 15:21 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 14,346 | $268.47 | $3,851,470.62 |
DisclosureSEC source: 0001062993-21-010469 · form4.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,361 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 22:47 UTC | KEYCORP /NEW/ KEY · Entity 3220 | Exercise / conversionDeferred Shares · Derivative | 6,781 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000091576-21-000102 · wf-form4_162561161808616.xml · derivative · entry 3 BROUSSARD BRUCE D · CIK 0001185643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,263 Underlying: Common Shares · 6,781 shares Expires 2021-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Share is the economic equivalent of one Common Share. F1 · price: Each Deferred Share is the economic equivalent of one Common Share. F3 · balance_after: Includes approximately 288 dividend-equivalent deferred shares accrued under the Deferred Share Plan in June 2021. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 22:47 UTC | KEYCORP /NEW/ KEY · Entity 3220 | Exercise / conversionCommon Shares | 6,781 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000091576-21-000102 · wf-form4_162561161808616.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,587 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Share is the economic equivalent of one Common Share. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 21:09 UTC | HP INC HPQ · Entity 642 | GrantCommon Stock | 5,213 | $29.14 | $151,906.82 |
DisclosureSEC source: 0001562180-21-004487 · primarydocument.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,213 F1 · shares: On 6/22/2021, the reporting person was granted 5,213 restricted stock units ("RSUs"), all of which vested on the grant date. Read SEC document |
| May 13, 2021 Filed May 17, 2021 20:53 UTC | KEYCORP /NEW/ KEY · Entity 3220 | GrantDeferred Shares · Derivative | 5,654 | $0.00 | $0.00 |
DisclosureSEC source: 0000091576-21-000083 · wf-form4_162128476995773.xml · derivative · entry 3 BROUSSARD BRUCE D · CIK 0001185643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,755 Underlying: Common Shares · 5,654 shares Expires not disclosed F2 · derivative.exercise_price: Each Deferred Share is the economic equivalent of one Common Share. F4 · price: The Deferred Shares were awarded under the Deferred Share Plan. F3 · derivative.exercise_date: Under the terms of KeyCorp's Directors' Deferred Share Sub-Plan of the KeyCorp 2019 Equity Compensation Plan (the "Deferred Share Plan"), the Participant will receive payment of the Deferred Shares one-half as Common Shares and one-half in cash on May 13, 2024. F3 · derivative.expiration_date: Under the terms of KeyCorp's Directors' Deferred Share Sub-Plan of the KeyCorp 2019 Equity Compensation Plan (the "Deferred Share Plan"), the Participant will receive payment of the Deferred Shares one-half as Common Shares and one-half in cash on May 13, 2024. F5 · balance_after: Includes approximately 1342 dividend-equivalent deferred shares accrued under the Deferred Share Plan between June 2020 and March 2021. Read SEC document |
| February 23, 2021 Filed Feb 24, 2021 01:41 UTC | HUMANA INC HUM · Entity 1429 | SaleHumana Common | 27,537 | $378.14 | $10,412,717.26 |
DisclosureSEC source: 0000049071-21-000057 · edgar.xml · nonDerivative · entry 3 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,015 F11 · price: Price reported is weighted avg sales price. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 01:41 UTC | HUMANA INC HUM · Entity 1429 | GrantRestricted Stock Units · Derivative | 7,393 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-21-000057 · edgar.xml · derivative · entry 10 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,393 Underlying: Humana Common · 7,393 shares Expires not disclosed F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F9 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23. F9 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 01:41 UTC | HUMANA INC HUM · Entity 1429 | GrantOptions · Derivative | 30,425 | $0.00 Strike: $376.61 | $0.00 |
DisclosureSEC source: 0000049071-21-000057 · edgar.xml · derivative · entry 7 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,425 Underlying: Humana Common · 30,425 shares Expires 2028-02-22 F4 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments. F4 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments. Read SEC document |
| February 19, 2021 Filed Feb 24, 2021 01:41 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 15,809 | $377.42 | $5,966,553.74 |
DisclosureSEC source: 0000049071-21-000057 · edgar.xml · nonDerivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,552 Read SEC document |
| February 19, 2021 Filed Feb 24, 2021 01:41 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 40,972 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-21-000057 · edgar.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,361 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · shares: Includes Performance Stock Units that vested 2/19/21. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 15:19 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 2,672 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-20-000162 · edgar.xml · derivative · entry 12 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,346 Underlying: Humana Common · 2,672 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F8 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22. F8 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 15:19 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 3,044 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-20-000162 · edgar.xml · derivative · entry 11 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,045 Underlying: Humana Common · 3,044 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/25/2019, 33% of the award is vesting on 12/15/19, 12/15/20, and 12/15/21. F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/25/2019, 33% of the award is vesting on 12/15/19, 12/15/20, and 12/15/21. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 15:19 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 3,415 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-20-000162 · edgar.xml · derivative · entry 10 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 3,415 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/19/2018, 33% of the award is vesting on 12/15/18, 12/15/19, and 12/15/20. F6 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/19/2018, 33% of the award is vesting on 12/15/18, 12/15/19, and 12/15/20. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 15:19 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 1,052 | $390.49 | $410,790.22 |
DisclosureSEC source: 0000049071-20-000162 · edgar.xml · nonDerivative · entry 6 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,389 Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 15:19 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 2,672 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-20-000162 · edgar.xml · nonDerivative · entry 5 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,441 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 15:19 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 1,198 | $390.49 | $467,801.03 |
DisclosureSEC source: 0000049071-20-000162 · edgar.xml · nonDerivative · entry 4 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,769 Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 15:19 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 3,044 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-20-000162 · edgar.xml · nonDerivative · entry 3 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,967 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 15:19 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 1,344 | $390.49 | $524,811.84 |
DisclosureSEC source: 0000049071-20-000162 · edgar.xml · nonDerivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,923 Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 15:19 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 3,415 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-20-000162 · edgar.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,267 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 18:52 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionOptions · Derivative | 29,434 | $0.00 Strike: $268.47 | $0.00 |
DisclosureSEC source: 0000049071-20-000147 · edgar.xml · derivative · entry 12 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,718 Underlying: Humana Common · 29,434 shares Expires 2025-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/19/2018, vesting in three annual increments. F2 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/19/2018, vesting in three annual increments. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 18:52 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionOptions · Derivative | 35,636 | $0.00 Strike: $217.42 | $0.00 |
DisclosureSEC source: 0000049071-20-000147 · edgar.xml · derivative · entry 11 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 35,636 shares Expires 2024-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017, vesting in three annual increments. F1 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017, vesting in three annual increments. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 18:52 UTC | HUMANA INC HUM · Entity 1429 | SaleHumana Common | 64,611 | $451.15 | $29,149,142.81 |
DisclosureSEC source: 0000049071-20-000147 · edgar.xml · nonDerivative · entry 5 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,518 F16 · price: Shares sold at prices ranging from $445.525 to $457.155. Price reported is weighted average sales price. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 18:52 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 29,434 | $268.47 | $7,902,145.98 |
DisclosureSEC source: 0000049071-20-000147 · edgar.xml · nonDerivative · entry 4 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,129 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 18:52 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 35,177 | $217.42 | $7,648,007.46 |
DisclosureSEC source: 0000049071-20-000147 · edgar.xml · nonDerivative · entry 3 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,695 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 18:52 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 238 | $420.05 | $99,972.50 |
DisclosureSEC source: 0000049071-20-000147 · edgar.xml · nonDerivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,518 F15 · shares: Shares swapped for the payment of purchase price on stock option exercise using fair market value on November 3, 2020 pursuant to Humana Inc.'s 2011 Stock Incentive Plan. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 18:52 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 459 | $217.42 | $99,793.49 |
DisclosureSEC source: 0000049071-20-000147 · edgar.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,756 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 25, 2020 Filed Nov 6, 2020 18:52 UTC | HUMANA INC HUM · Entity 1429 | GiftHumana Common | 6,160 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-20-000147 · edgar.xml · nonDerivative · entry 10 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,852 F14 · shares: Shares transferred represent a gift to a Trust in the name of affiliate's son, effective August 25, 2020. Affiliate is not a Trustee and has no pecuniary interest or investment discretion. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.